GLP-1 and the Evidence: What the Research Actually Says
GLP-1 therapy is the most significant development in metabolic medicine in a generation. Here is what the evidence shows — and what it does not.
Evidence-based perspectives from Dr. Harris and Dr. Olaleye — on treatments, metabolic health, and the science of skin.
GLP-1 therapy is the most significant development in metabolic medicine in a generation. Here is what the evidence shows — and what it does not.
When a teenager asks about their skin, the answer matters more than most parents realize. A physician's guide to adolescent skincare — and when to seek professional help.
Melasma is one of the most misunderstood conditions in aesthetics. Samuel Olaleye, MD breaks down what actually works, what doesn't, and why a layered approach is the only honest answer.
Both are botulinum toxin. Both relax muscles. So why does it matter which one you choose? Samuel Olaleye, MD explains the clinical differences — and when each one is the right call.
GLP-1 medications are the most talked-about development in weight medicine in decades. They are also the most misunderstood. Samuel Olaleye, MD separates fact from fiction.
Polycystic ovary syndrome affects up to 10% of women of reproductive age and is one of the most common reasons weight loss feels impossible. Samuel Olaleye, MD explains the biology — and the path forward.
Every decade brings different skin concerns, different priorities, and different opportunities. Samuel Olaleye, MD shares what he recommends — and what he's seen work — at every stage of life.